Category Messenger

‘Encouraging’ Early Data for mRNA Vaccine in Glioblastoma

‘Encouraging’ Early Data for mRNA Vaccine in Glioblastoma

BARCELONA — In a first-in-human clinical trial, an investigational messenger RNA (mRNA)-based cancer vaccine for glioblastoma induced tumor-associated antigen-specific T-cell responses in more than three quarters of patients and had an acceptable safety profile.  “These early data are encouraging,” Ghazaleh…

MESSENGER – From Setbacks to Success

MESSENGER – From Setbacks to Success

The excerpts below are taken from Discovery Program oral history interviews conducted in 2009 by Dr. Susan Niebur and tell the story of the hurdles the MESSENGER (MErcury Surface, Space ENvironment, GEochemistry, and Ranging) mission team faced with the technical…